{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:51:21Z","timestamp":1777611081872,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100008065","name":"Georgia Research Alliance","doi-asserted-by":"crossref","award":["GRA.VL17.11"],"award-info":[{"award-number":["GRA.VL17.11"]}],"id":[{"id":"10.13039\/100008065","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA12970"],"award-info":[{"award-number":["DA12970"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s13346-019-00685-4","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T14:51:49Z","timestamp":1571842309000},"page":"271-281","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The pharmacokinetics of 3-fluoroamphetamine following delivery using clinically relevant routes of administration"],"prefix":"10.1007","volume":"10","author":[{"given":"Ying","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azizi","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Shajid Ashraf","family":"Junaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonalika Arup","family":"Bhattaccharjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayla","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay K.","family":"Banga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce E.","family":"Blough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8143-0541","authenticated-orcid":false,"given":"Kevin S.","family":"Murnane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,22]]},"reference":[{"issue":"8","key":"685_CR1","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1176\/appi.ajp.162.8.1432","volume":"162","author":"Frank J. Vocci","year":"2005","unstructured":"Vocci FJ, Acri J, Elkashef A. Medication development for addictive disorders: the state of the science. Am J Psychiatry. 2005;162:1432\u201340.","journal-title":"American Journal of Psychiatry"},{"key":"685_CR2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1360-0443.2007.01772.x","volume":"102","author":"Frank J. Vocci","year":"2007","unstructured":"Vocci FJ, Appel NM. Approaches to the development of medications for the treatment of methamphetamine dependence. Addiction. 2007;102:96\u2013106.","journal-title":"Addiction"},{"issue":"12","key":"685_CR3","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/nrn1539","volume":"5","author":"Nora D. Volkow","year":"2004","unstructured":"Volkow ND, Li T-K. Drug addiction: the neurobiology of behaviour gone awry. Nat Rev Neurosci. 2004;5(12):963\u201370.","journal-title":"Nature Reviews Neuroscience"},{"issue":"1","key":"685_CR4","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1196\/annals.1441.023","volume":"1141","author":"LL Howell","year":"2008","unstructured":"Howell LL, Murnane KS. Nonhuman primate neuroimaging and the neurobiology of psychostimulant addiction. Ann N Y Acad Sci. 2008;1141(1):176\u201394.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"685_CR5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00213-010-1839-2","volume":"210","author":"ML Andersen","year":"2010","unstructured":"Andersen ML, Kessler E, Murnane KS, McClung JC, Tufik S, Howell LL. Dopamine transporter-related effects of modafinil in rhesus monkesy. Psychopharmacology. 2010;210(3):439\u201348.","journal-title":"Psychopharmacology"},{"issue":"2","key":"685_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00213-011-2222-7","volume":"216","author":"KS Murnane","year":"2011","unstructured":"Murnane KS, Howell LL. Neuroimaging and drug taking in primates. Psychopharmacology. 2011;216(2):153\u201371.","journal-title":"Psychopharmacology"},{"issue":"2","key":"685_CR7","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1124\/jpet.108.136689","volume":"337","author":"LL Howell","year":"2011","unstructured":"Howell LL, Murnane KS. Nonhuman primate positron emission tomography neuroimaging in drug abuse research. J Pharmacol Exp Ther. 2011;337(2):324\u201334.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"685_CR8","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.bcp.2007.08.003","volume":"75","author":"LL Howell","year":"2008","unstructured":"Howell LL, Kimmel HL. Monoamine transporters and psychostimulant addiction. Biochem Pharmacol. 2008;75(1):196\u2013217.","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"685_CR9","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/0006-2952(86)90148-6","volume":"35","author":"MEA Reith","year":"1986","unstructured":"Reith MEA, Meisler BE, Sershen H, Lajtha A. Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behavior. Biochem Pharmacol. 1986;35(7):1123\u20139.","journal-title":"Biochem Pharmacol"},{"key":"685_CR10","unstructured":"Bergman J, Madras BK, Johnson SE, Spealman RD. Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. J Pharmacol Exp Ther. 1989."},{"issue":"8","key":"685_CR11","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1097\/FBP.0b013e32834d63ac","volume":"22","author":"ML Banks","year":"2011","unstructured":"Banks ML, Blough BE, Negus SS. Effects of monoamine releasers with varying selectivity for releasing dopamine\/norepinephrine versus serotonin on choice between cocaine and food in rhesus monkeys. Behav Pharmacol. 2011;22(8):824\u201336.","journal-title":"Behav Pharmacol"},{"issue":"1","key":"685_CR12","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1124\/jpet.108.143701","volume":"329","author":"SS Negus","year":"2009","unstructured":"Negus SS, Baumann MH, Rothman RB, Mello NK, Blough BE. Selective suppression of cocaine- versus food-maintained responding by monoamine releasers in rhesus monkeys: benzylpiperazine, (+)phenmetrazine, and 4-benzylpiperidine. J Pharmacol Exp Ther. 2009;329(1):272\u201381.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"685_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0376-8716(02)00339-3","volume":"70","author":"SS Negus","year":"2003","unstructured":"Negus SS, Mello NK. Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a second-order schedule in rhesus monkeys. Drug Alcohol Depend. 2003;70(1):39\u201352.","journal-title":"Drug Alcohol Depend"},{"issue":"13","key":"685_CR14","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1038\/npp.2013.180","volume":"38","author":"ML Banks","year":"2013","unstructured":"Banks ML, Blough BE, Fennell TR, Snyder RW, Negus SS. Effects of phendimetrazine treatment on cocaine vs food choice and extended-access cocaine consumption in rhesus monkeys. Neuropsychopharmacology. 2013;38(13):2698\u2013707.","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"685_CR15","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.pbb.2009.09.007","volume":"94","author":"HL Kimmel","year":"2009","unstructured":"Kimmel HL, Manvich DF, Blough BE, Negus SS, Howell LL. Behavioral and neurochemical effects of amphetamine analogs that release monoamines in the squirrel monkey. Pharmacol Biochem Behav. 2009;94(2):278\u201384.","journal-title":"Pharmacol Biochem Behav"},{"issue":"7","key":"685_CR16","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.addbeh.2004.06.018","volume":"29","author":"John Grabowski","year":"2004","unstructured":"Grabowski J, Shearer J, Merrill J, Negus SS. Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addict Behav. 2004;29(7):1439\u201364.","journal-title":"Addictive Behaviors"},{"issue":"8","key":"685_CR17","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1038\/npp.2014.322","volume":"40","author":"S Stevens Negus","year":"2014","unstructured":"Negus SS, Henningfield J. Agonist medications for the treatment of cocaine use disorder. Neuropsychopharmacology. 2015;40:1815\u201325.","journal-title":"Neuropsychopharmacology"},{"issue":"1\u20132","key":"685_CR18","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ijpharm.2017.06.041","volume":"528","author":"A Puri","year":"2017","unstructured":"Puri A, Murnane KS, Blough BE, Banga AK. Effects of chemical and physical enhancement techniques on transdermal delivery of 3-fluoroamphetamine hydrochloride. Int J Pharm. 2017;528(1\u20132):452\u201362.","journal-title":"Int J Pharm"},{"issue":"4","key":"685_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1208\/s12248-019-0335-9","volume":"21","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, Murnane KS, Bhattaccharjee SA, Blough BE, Banga AK. Skin delivery and irritation potential of phenmetrazine as a candidate transdermal formulation for repurposed indications. AAPS J. 2019;21(4):70.","journal-title":"AAPS J"},{"issue":"1\u20132","key":"685_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ijpharm.2018.08.033","volume":"550","author":"SS Ganti","year":"2018","unstructured":"Ganti SS, Bhattaccharjee SA, Murnane KS, Blough BE, Banga AK. Formulation and evaluation of 4-benzylpiperidine drug-in-adhesive matrix type transdermal patch. Int J Pharm. 2018;550(1\u20132):71\u20138.","journal-title":"Int J Pharm"},{"issue":"11","key":"685_CR21","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1176\/appi.ajp.160.11.1909","volume":"160","author":"ND Volkow","year":"2003","unstructured":"Volkow ND, Swanson JM. Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am J Psychiatry. 2003;160(11):1909\u201318.","journal-title":"Am J Psychiatry"},{"issue":"2\u20133","key":"685_CR22","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/BF02245161","volume":"107","author":"H de Wit","year":"1992","unstructured":"de Wit H, Bodker B, Ambre J. Rate of increase of plasma drug level influences subjective response in humans. Psychopharmacology. 1992;107(2\u20133):352\u20138.","journal-title":"Psychopharmacology"},{"issue":"1\u20132","key":"685_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jchromb.2006.12.030","volume":"852","author":"E Chambers","year":"2007","unstructured":"Chambers E, Wagrowski-Diehl DM, Lu Z, Mazzeo JR. Systematic and comprehensive strategy for reducing matrix effects in LC\/MS\/MS analyses. J Chromatogr B Anal Technol Biomed Life Sci. 2007;852(1\u20132):22\u201334.","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"key":"685_CR24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jchromb.2013.08.009","volume":"937","author":"L Zhang","year":"2013","unstructured":"Zhang L, Jiang Y, Jing G, Tang Y, Chen X, Yang D, et al. A novel UPLC\u2013ESI-MS\/MS method for the quantitation of disulfiram, its role in stabilized plasma and its application. J Chromatogr B. 2013;937:54\u20139.","journal-title":"J Chromatogr B"},{"issue":"11","key":"685_CR25","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1016\/j.xphs.2018.07.015","volume":"107","author":"P Bakshi","year":"2018","unstructured":"Bakshi P, Jiang Y, Nakata T, Akaki J, Matsuoka N, Banga AK. Formulation development and characterization of nanoemulsion-based formulation for topical delivery of heparinoid. J Pharm Sci. 2018;107(11):2883\u201390.","journal-title":"J Pharm Sci"},{"issue":"7","key":"685_CR26","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1007\/s11095-007-9308-2","volume":"24","author":"AV Badkar","year":"2007","unstructured":"Badkar AV, Smith AM, Eppstein JA, Banga AK. Transdermal delivery of interferon alpha-2b using microporation and iontophoresis in hairless rats. Pharm Res. 2007;24(7):1389\u201395.","journal-title":"Pharm Res"},{"issue":"3","key":"685_CR27","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1177\/1087054705284089","volume":"9","author":"James J. McGough","year":"2006","unstructured":"McGough JJ, Wigal SB, Abikoff H, Turnbow JM, Posner K, Moon E. A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD. J Atten Disord. 2006;9(3):476\u201385.","journal-title":"Journal of Attention Disorders"},{"issue":"9","key":"685_CR28","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1124\/dmd.111.039446","volume":"39","author":"S White","year":"2011","unstructured":"White S, Laurenzana E, Hendrickson H, Gentry WB, Owens SM. Gestation time-dependent pharmacokinetics of intravenous (+)-methamphetamine in rats. Drug Metab Dispos. 2011;39(9):1718\u201326.","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"685_CR29","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/jps.2600660633","volume":"66","author":"J Gal","year":"1977","unstructured":"Gal J, Hodshon BJ, Pintauro C, Flamm BL, Cho AK. Pharmacokinetics of methylphenidate in the rat using single-ion monitoring GLC-mass spectrometry. J Pharm Sci. 1977;66(6):866\u20139.","journal-title":"J Pharm Sci"},{"issue":"13","key":"685_CR30","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1007\/s00213-015-3875-4","volume":"232","author":"PW Czoty","year":"2015","unstructured":"Czoty PW, Tran P, Thomas LN, Martin TJ, Grigg A, Blough BE, et al. Effects of the dopamine\/norepinephrine releaser phenmetrazine on cocaine self-administration and cocaine-primed reinstatement in rats. Psychopharmacology. 2015;232(13):2405\u201314.","journal-title":"Psychopharmacology"},{"issue":"5","key":"685_CR31","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00213-013-3305-4","volume":"231","author":"BA Zimmer","year":"2014","unstructured":"Zimmer BA, Chiodo KA, Roberts DCS. Reduction of the reinforcing effectiveness of cocaine by continuous d-amphetamine treatment in rats: Importance of active self-administration during treatment period. Psychopharmacology. 2014;231(5):949\u201354.","journal-title":"Psychopharmacology"},{"issue":"3","key":"685_CR32","first-page":"98","volume":"3","author":"K Saroha","year":"2011","unstructured":"Saroha K, Yadav B, Sharma B. Transdermal patch: a discrete dosage form. Int J Curr Pharm Res. 2011;3(3):98\u2013108.","journal-title":"Int J Curr Pharm Res"},{"key":"685_CR33","doi-asserted-by":"crossref","unstructured":"Banga AK. Transdermal and intradermal delivery of therapeutic agents application of physical technologies. Boca Raton, Florida: CRC press; 2011.","DOI":"10.1201\/b10906"},{"issue":"s6","key":"685_CR34","doi-asserted-by":"publisher","first-page":"44s","DOI":"10.1111\/1523-1747.ep12537108","volume":"80","author":"PM Elias","year":"1983","unstructured":"Elias PM. Epidermal lipids, barrier function, and desquamation. J Investig Dermatol. 1983;80(s6):44s\u20139s.","journal-title":"J Investig Dermatol"},{"issue":"4","key":"685_CR35","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/syn.20235","volume":"59","author":"W.K. Schiffer","year":"2005","unstructured":"Schiffer WK, Volkow ND, Fowler JS, Alexoff DL, Logan J, Dewey SL. Therapeutic doses of amphetamine or methylphenidate differentially increase synaptic and extracellular dopamine. Synapse. 2006;59(4):243\u201351.","journal-title":"Synapse"},{"issue":"2","key":"685_CR36","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1124\/jpet.104.080101","volume":"313","author":"S. Wee","year":"2005","unstructured":"Wee S, Anderson KG, Baumann MH, Rothman RB, Blough BE, Woolverton WL. Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs. J Pharmacol Exp Ther. 2005;313(2):848\u201354.","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"685_CR37","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jconrel.2015.05.263","volume":"210","author":"Yang Yang","year":"2015","unstructured":"Yang Y, Manda P, Pavurala N, Khan MA, Krishnaiah YSR. Development and validation of in vitro\u2013in vivo correlation (IVIVC) for estradiol transdermal drug delivery systems. J Control Release. 2015;210:58\u201366.","journal-title":"Journal of Controlled Release"},{"key":"685_CR38","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jconrel.2017.11.034","volume":"270","author":"SH Shin","year":"2018","unstructured":"Shin SH, Thomas S, Raney SG, Ghosh P, Hammell DC, El-Kamary SS, et al. In vitro\u2013in vivo correlations for nicotine transdermal delivery systems evaluated by both in vitro skin permeation (IVPT) and in vivo serum pharmacokinetics under the influence of transient heat application. J Control Release. 2018;270:76\u201388.","journal-title":"J Control Release"},{"issue":"9","key":"685_CR39","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.4155\/tde.15.72","volume":"6","author":"Priyanka Ghosh","year":"2015","unstructured":"Ghosh P, Milewski M, Paudel K. In vitro\/in vivo correlations in transdermal product development. Ther Deliv. 2015;6:1117\u201324.","journal-title":"Therapeutic Delivery"},{"issue":"10","key":"685_CR40","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1021\/mp400227e","volume":"10","author":"M Milewski","year":"2013","unstructured":"Milewski M, Paudel KS, Brogden NK, Ghosh P, Banks SL, Hammell DC, et al. Microneedle-assisted percutaneous delivery of naltrexone hydrochloride in yucatan minipig: in vitro-in vivo correlation. Mol Pharm. 2013;10(10):3745\u201357.","journal-title":"Mol Pharm"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-019-00685-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13346-019-00685-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-019-00685-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T23:33:32Z","timestamp":1603236812000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13346-019-00685-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,22]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["685"],"URL":"https:\/\/doi.org\/10.1007\/s13346-019-00685-4","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,22]]},"assertion":[{"value":"22 October 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All institutional and national guidelines for the care and use of laboratory animals were followed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None of the authors has a financial relationship with the sponsor of the research, which was the Georgia Research Alliance. The Georgia Research Alliance is a state government funded agency. Ajay Banga and Kevin Murnane are cofounders of DD Therapeutics, a for-profit startup company that aims to commercialize drug-delivery technology. Ajay Banga, Kevin Murnane, and Ying Jiang are co-inventors on a patent pending for transdermal use of phenethylamine monoamine releasers that is owned by Mercer University. Azizi Ray, Mohammad Shajid Ashraf Junaid, Sonalika Arup Bhattaccharjee, Kayla Kelley, and Bruce Blough have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}